As we celebrate Senior Pet Health Month, it’s crucial to shed light on the unique challenges faced by our aging furry friends. One of the most common issues affecting senior pets is reduced mobility, which can lead to a decrease in their overall quality of life. Fortunately, there are various strategies and treatments available to help senior pets maintain their mobility and live their golden years to the fullest.
Just like humans, pets experience age-related changes that can impact their mobility. Senior pets may face issues such as arthritis, joint pain, and reduced muscle mass, which can make it difficult for them to move, play, or even perform essential activities like getting up and down. Reduced mobility not only affects their physical health but can also lead to obesity, which exacerbates joint issues and contributes to a downward spiral of inactivity.
Librela and Solensia are game-changers when it comes to controlling osteoarthritis (OA) pain, a condition that affects both dogs and cats. By decreasing OA pain, these monthly injections can enhance your senior pet’s activity levels and improve their overall quality of life.
What sets Librela and Solensia apart is their mode of action. These monoclonal antibodies function similarly to your pet’s naturally occurring antibodies, which is gentle on their liver and kidneys. This means you can provide effective pain relief without worrying about additional stress on your pet’s vital organs.
Both Librela and Solensia have been available in Europe since 2021, and they’ve already made a significant impact. With millions of doses distributed, they have demonstrated their effectiveness in managing OA pain in dogs and cats, earning the trust of veterinarians and pet owners alike.
Although the full effects of Librela and Solensia may take until after the second injection, some dogs may experience a decrease in OA pain symptoms as soon as seven days after the first injection. Individual responses may vary, but the potential for a happier, more active dog is worth exploring.
Librela and Solensia are approved as safe for dogs and cats, respectively. However, it’s crucial to have a conversation with your vet to confirm that they are the right choice for your pet. For example, they should not be used in pets with a sensitivity to the active ingredients.
These revolutionary medications are the first and only anti-NGF monoclonal antibody for controlling OA pain in dogs and cats. Administered as a once-monthly injection, they offer a safe and effective alternative to daily oral medications. Your veterinarian is your best resource for determining whether Librela or Solensia is the right choice for your pet.
Senior Pet Health Month serves as an excellent opportunity to focus on the well-being of our aging furry companions. Librela and Solensia offer a beacon of hope for senior pet mobility and the enhancement of their quality of life. By reducing pain, improving mobility, and restoring happiness, these medications can provide more precious moments in comfort with your best friend, be it a dog or a cat. Talk to your vet about OA screening and how treatment with Librela and Solensia can make a significant difference, renewing vitality and mobility in your beloved senior pet.
Leave A Comment